These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18312222)

  • 21. Statistical data processing in clinical proteomics.
    Smit S; Hoefsloot HC; Smilde AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):77-88. PubMed ID: 18033744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer.
    Ragazzi E; Pucciarelli S; Seraglia R; Molin L; Agostini M; Lise M; Traldi P; Nitti D
    J Mass Spectrom; 2006 Dec; 41(12):1546-53. PubMed ID: 17117375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of two new serum protein profiles for renal cell carcinoma.
    Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH
    Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feature extraction and dimensionality reduction for mass spectrometry data.
    Liu Y
    Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SELDI-TOF serum proteomics and breast cancer: which perspective?
    Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
    Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
    van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
    Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
    Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
    J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic identification and profiling of canine lymphoma patients.
    Ratcliffe L; Mian S; Slater K; King H; Napolitano M; Aucoin D; Mobasheri A
    Vet Comp Oncol; 2009 Jun; 7(2):92-105. PubMed ID: 19453363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
    Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles.
    Rajalahti T; Arneberg R; Kroksveen AC; Berle M; Myhr KM; Kvalheim OM
    Anal Chem; 2009 Apr; 81(7):2581-90. PubMed ID: 19228047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International competition on mass spectrometry proteomic diagnosis.
    Mertens B
    Stat Appl Genet Mol Biol; 2008; 7(2):Article1. PubMed ID: 19852745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
    Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
    J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum protein profiles in myasthenia gravis.
    Cheng C; Wu G; Yeung SC; Li R; Bella AE; Pang J; Zhong FT; Luo H; Jin Y; Pan J
    Ann Thorac Surg; 2009 Oct; 88(4):1118-23. PubMed ID: 19766792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.